Matt O'Brien
Stock Analyst at Piper Sandler
(2.27)
# 1,423
Out of 4,412 analysts
106
Total ratings
42.57%
Success rate
-4.62%
Average return
Main Sectors:
33 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNMD CONMED | Maintains: Overweight | $100 → $95 | $67.98 | +39.75% | 7 | Apr 25, 2024 | |
| PEN Penumbra | Reiterates: Overweight | $290 | $196.47 | +47.61% | 7 | Apr 3, 2024 | |
| SIBN SI-BONE | Initiates: Overweight | $25 | $14.26 | +75.32% | 1 | Mar 28, 2024 | |
| TMDX TransMedics Group | Initiates: Overweight | $95 | $94.13 | +0.92% | 1 | Mar 28, 2024 | |
| FNA Paragon 28 | Maintains: Overweight | $18 | $9.22 | +95.23% | 2 | Mar 27, 2024 | |
| TELA TELA Bio | Maintains: Overweight | $15 → $12 | $4.51 | +166.37% | 2 | Mar 22, 2024 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $40 → $33 | $45.96 | -28.20% | 5 | Feb 27, 2024 | |
| RCEL AVITA Medical | Reiterates: Overweight | $19 → $21 | $8.40 | +150.00% | 5 | Feb 23, 2024 | |
| PODD Insulet | Maintains: Overweight | $250 → $230 | $171.94 | +33.77% | 6 | Feb 23, 2024 | |
| CVRX CVRx, Inc. | Maintains: Overweight | $21 → $33 | $15.51 | +112.77% | 4 | Jan 26, 2024 | |
| GKOS Glaukos | Maintains: Overweight | $90 → $105 | $96.00 | +9.38% | 6 | Dec 22, 2023 | |
| DXCM DexCom | Maintains: Overweight | $135 → $150 | $127.39 | +17.75% | 8 | Dec 19, 2023 | |
| HUMA Humacyte | Maintains: Neutral | $3.5 → $3 | $3.92 | -23.47% | 2 | Nov 10, 2023 | |
| CUTR Cutera | Maintains: Neutral | $18 → $3 | $2.42 | +23.97% | 5 | Nov 9, 2023 | |
| TFX Teleflex | Maintains: Neutral | $210 → $225 | $208.75 | +7.78% | 2 | Nov 6, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $40 → $25 | $36.69 | -31.86% | 5 | Nov 2, 2023 | |
| SGHT Sight Sciences | Downgrades: Neutral | $15 → $5.5 | $5.55 | -0.90% | 4 | Sep 12, 2023 | |
| APYX Apyx Medical | Maintains: Overweight | $4 → $4.5 | $1.43 | +214.69% | 2 | Aug 11, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Overweight | $42 | $52.98 | -20.72% | 1 | Aug 11, 2023 | |
| BSX Boston Scientific | Maintains: Overweight | $58 → $62 | $71.87 | -13.73% | 2 | Jul 6, 2023 | |
| UTRS Minerva Surgical | Maintains: Overweight | $100 → $20 | $0.00 | +1,999,900.00% | 5 | May 3, 2023 | |
| SYK Stryker | Maintains: Overweight | $280 → $310 | $336.50 | -7.88% | 6 | May 2, 2023 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Overweight | n/a | $120.28 | - | 2 | Mar 10, 2023 | |
| OBIO Orchestra BioMed Holdings | Initiates: Overweight | $15 | $4.41 | +240.14% | 1 | Feb 24, 2023 | |
| ITGR Integer Holdings | Initiates: Overweight | $85 | $111.63 | -23.86% | 1 | Feb 24, 2023 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $49.79 | - | 4 | Feb 9, 2023 | |
| MOTS Motus GI Holdings | Maintains: Overweight | $150 → $90 | $0.08 | +118,336.64% | 1 | Nov 15, 2022 | |
| ATRC AtriCure | Maintains: Overweight | $90 → $55 | $24.12 | +128.03% | 1 | Aug 3, 2022 | |
| MDT Medtronic | Maintains: Neutral | $105 → $100 | $80.24 | +24.63% | 3 | May 27, 2022 | |
| COO The Cooper Companies | Maintains: Overweight | $93 → $109 | $89.06 | +22.11% | 1 | Feb 11, 2021 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $10.97 | - | 2 | Jan 29, 2021 | |
| BAX Baxter International | Downgrades: Neutral | n/a | $40.37 | - | 1 | Jan 29, 2021 | |
| KRMD KORU Medical Systems | Initiates: Overweight | n/a | $2.17 | - | 1 | Jun 24, 2020 |
CONMED
Apr 25, 2024
Maintains: Overweight
Price Target: $100 → $95
Current: $67.98
Upside: +39.75%
Penumbra
Apr 3, 2024
Reiterates: Overweight
Price Target: $290
Current: $196.47
Upside: +47.61%
SI-BONE
Mar 28, 2024
Initiates: Overweight
Price Target: $25
Current: $14.26
Upside: +75.32%
TransMedics Group
Mar 28, 2024
Initiates: Overweight
Price Target: $95
Current: $94.13
Upside: +0.92%
Paragon 28
Mar 27, 2024
Maintains: Overweight
Price Target: $18
Current: $9.22
Upside: +95.23%
TELA Bio
Mar 22, 2024
Maintains: Overweight
Price Target: $15 → $12
Current: $4.51
Upside: +166.37%
STAAR Surgical Company
Feb 27, 2024
Maintains: Neutral
Price Target: $40 → $33
Current: $45.96
Upside: -28.20%
AVITA Medical
Feb 23, 2024
Reiterates: Overweight
Price Target: $19 → $21
Current: $8.40
Upside: +150.00%
Insulet
Feb 23, 2024
Maintains: Overweight
Price Target: $250 → $230
Current: $171.94
Upside: +33.77%
CVRx, Inc.
Jan 26, 2024
Maintains: Overweight
Price Target: $21 → $33
Current: $15.51
Upside: +112.77%
Glaukos
Dec 22, 2023
Maintains: Overweight
Price Target: $90 → $105
Current: $96.00
Upside: +9.38%
DexCom
Dec 19, 2023
Maintains: Overweight
Price Target: $135 → $150
Current: $127.39
Upside: +17.75%
Humacyte
Nov 10, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $3.92
Upside: -23.47%
Cutera
Nov 9, 2023
Maintains: Neutral
Price Target: $18 → $3
Current: $2.42
Upside: +23.97%
Teleflex
Nov 6, 2023
Maintains: Neutral
Price Target: $210 → $225
Current: $208.75
Upside: +7.78%
Tandem Diabetes Care
Nov 2, 2023
Maintains: Overweight
Price Target: $40 → $25
Current: $36.69
Upside: -31.86%
Sight Sciences
Sep 12, 2023
Downgrades: Neutral
Price Target: $15 → $5.5
Current: $5.55
Upside: -0.90%
Apyx Medical
Aug 11, 2023
Maintains: Overweight
Price Target: $4 → $4.5
Current: $1.43
Upside: +214.69%
PROCEPT BioRobotics
Aug 11, 2023
Initiates: Overweight
Price Target: $42
Current: $52.98
Upside: -20.72%
Boston Scientific
Jul 6, 2023
Maintains: Overweight
Price Target: $58 → $62
Current: $71.87
Upside: -13.73%
Minerva Surgical
May 3, 2023
Maintains: Overweight
Price Target: $100 → $20
Current: $0.00
Upside: +1,999,900.00%
Stryker
May 2, 2023
Maintains: Overweight
Price Target: $280 → $310
Current: $336.50
Upside: -7.88%
Zimmer Biomet Holdings
Mar 10, 2023
Upgrades: Overweight
Price Target: n/a
Current: $120.28
Upside: -
Orchestra BioMed Holdings
Feb 24, 2023
Initiates: Overweight
Price Target: $15
Current: $4.41
Upside: +240.14%
Integer Holdings
Feb 24, 2023
Initiates: Overweight
Price Target: $85
Current: $111.63
Upside: -23.86%
Globus Medical
Feb 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $49.79
Upside: -
Motus GI Holdings
Nov 15, 2022
Maintains: Overweight
Price Target: $150 → $90
Current: $0.08
Upside: +118,336.64%
AtriCure
Aug 3, 2022
Maintains: Overweight
Price Target: $90 → $55
Current: $24.12
Upside: +128.03%
Medtronic
May 27, 2022
Maintains: Neutral
Price Target: $105 → $100
Current: $80.24
Upside: +24.63%
The Cooper Companies
Feb 11, 2021
Maintains: Overweight
Price Target: $93 → $109
Current: $89.06
Upside: +22.11%
Zynex
Jan 29, 2021
Downgrades: Neutral
Price Target: n/a
Current: $10.97
Upside: -
Baxter International
Jan 29, 2021
Downgrades: Neutral
Price Target: n/a
Current: $40.37
Upside: -
KORU Medical Systems
Jun 24, 2020
Initiates: Overweight
Price Target: n/a
Current: $2.17
Upside: -